The global Onco-Hematology Molecular Testing Market is witnessing significant growth as healthcare systems increasingly adopt precision medicine for the diagnosis and treatment of blood cancers. According to industry estimates, the market was valued at US$ 511.3 million in 2022 and is projected to surpass US$ 1.5 billion by 2031, registering a robust CAGR of 12.5% from 2023 to 2031. The rising...